Which are the causes of Maroteaux-Lamy Syndrome?

Maroteaux-Lamy syndrome, also known as Mucopolysaccharidosis type VI (MPS VI), is caused by a genetic deficiency of the enzyme arylsulfatase B. This deficiency leads to the harmful accumulation of complex sugar molecules called glycosaminoglycans (GAGs) within the body’s cells, which progressively damages tissues and organs.

What causes Maroteaux-Lamy syndrome at the genetic level?

Maroteaux-Lamy syndrome is a metabolic disorder caused by mutations in the ARSB gene. This gene provides instructions for producing the enzyme arylsulfatase B. When the ARSB gene is mutated, the body cannot produce enough functional enzyme to break down dermatan sulfate, a type of glycosaminoglycan. Because these sugars are not recycled, they build up inside lysosomes—the "recycling centers" of the cell—eventually causing the cells to malfunction and leading to the systemic symptoms seen in Maroteaux-Lamy syndrome.

Is Maroteaux-Lamy syndrome hereditary?

Yes, Maroteaux-Lamy syndrome is an autosomal recessive disorder. This means that for a child to be born with the condition, they must inherit two copies of the mutated ARSB gene—one from each parent. Parents who carry only one mutated gene are "carriers" and typically do not exhibit symptoms of Maroteaux-Lamy syndrome. If both parents are carriers, there is a 25% chance with each pregnancy that the child will be born with the condition.

Are there environmental triggers for this condition?

Unlike some diseases, Maroteaux-Lamy syndrome is not caused by environmental factors, lifestyle choices, or infections. It is strictly a genetic condition present from conception. The progression of Maroteaux-Lamy syndrome is determined by the specific nature of the ARSB mutation, which influences how much residual enzyme activity the body retains. Current research is focused on gene therapy and substrate reduction therapy to address the underlying metabolic cause rather than external triggers.

Key facts about the pathophysiology of Maroteaux-Lamy syndrome

• Primary defect: Deficiency of the enzyme arylsulfatase B (ASB).


• Accumulation: Build-up of dermatan sulfate in various tissues.


• Inheritance pattern: Autosomal recessive.


• Disease classification: A lysosomal storage disorder.

Next steps

• Consult with a clinical geneticist to discuss family planning and carrier testing.


• Connect with the Maroteaux-Lamy syndrome community at DiseaseMaps.org to share experiences with the three members currently registered.


• Inquire with your specialist about enzyme replacement therapy (ERT), which helps manage the metabolic buildup.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Mucopolysaccharidosis type VI.


• Orphanet: Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).


• OMIM (Online Mendelian Inheritance in Man): ARSB Gene Entry.


• National MPS Society: Information on MPS VI.